Publications by authors named "Abdelfattah M Badawi"

Hepatocellular carcinoma (HCC) is one of the most leading causes of death worldwide. Previous studies reported that gallium alone and cetyltrimethylammonium bromide (CTAB) have antineoplastic activities; therefore, this study aimed to evaluate the activity of copper-cetyl tri-methyl ammonium bromide with gallium oxide nanoparticles (Cu-CTAB+GaO-NPs) against HCC by using and studies. study was performed to evaluate the cytotoxic effects of Cu-CTAB+GaO-NPs and GaO-NPs on HepG-2 cell line using crystal violet dye assay.

View Article and Find Full Text PDF

The objective of the present study was to evaluate the anticancer and radio-sensitizing efficacy of a Withania somnifera extract/Gadolinium III oxide nanocomposite (WSGNC) in mice. WSGNC was injected to solid Ehrlich carcinoma-bearing mice via i.p.

View Article and Find Full Text PDF

Reaction of 4,4-biphenyl-disulfonyl chloride with aromatic/heterocyclic sulfonamides also incorporating a free amino group, such as 4-aminobenzenesulfonamide, 4-aminoethyl-benzenesulfonamide, 6-chloro-4-aminobenzene-1,3-disulfonamide or 5-amino-1,3,4-thiadiazole-2-sulfonamide afforded bis-sulfonamides which have been tested as inhibitors of the zinc enzyme carbonic anhydrase (CA, EC 4..2.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Abdelfattah M Badawi"

  • Abdelfattah M Badawi's recent research focuses on developing novel nanocomposites with anticancer properties, specifically targeting hepatocellular carcinoma and other tumor types using various synthetic agents and methodologies.
  • A study published in June 2023 explored the efficacy of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles as a potential antitumor agent, demonstrating significant cytotoxic effects against the HepG-2 cell line.
  • Additionally, Badawi's earlier work in 2017 investigated the anticancer and radiosensitization capabilities of a Withania somnifera extract combined with Gadolinium III oxide in animal models, indicating promising therapeutic possibilities in cancer treatment.